Hints and tips:
...The Ghent-based company, spun off from Belgian drugmaker UCB in 2003 and bought by CVC four years later, made €715m in revenues last year....
...The US drugmaker beat UCB of Belgium and Nycomed of Switzerland to buy the division....
...Bayer fell 3.1 per cent to €47.35 and UCB fell 3.3 per cent to €28.84. DSM climbed 1.2 per cent to €28.55. The FTSE Eurofirst 300 declined 0.5 per cent to 997.56....
International Edition